Striatal neural grafting improves cortical metabolism in Huntington's disease patients.

Huntington's disease is a hereditary disease in which degeneration of neurons in the striatum leads to motor and cognitive deficits. Foetal striatal allografts reverse these deficits in phenotypic models of Huntington's disease developed in primates. A recent open-label pilot study has shown some clinical improvement or stabilization in three out of five Huntington's disease patients who received bilateral striatal grafts of foetal neurons. We show here that the clinical changes in these three patients were associated with a reduction of the striatal and cortical hypometabolism, demonstrating that grafts were able to restore the function of striato-cortical loops. Conversely, in the two patients not improved by the grafts, striatal and cortical hypometabolism progressed over the 2-year follow-up. Finally, detailed anatomical-functional analysis of the grafted striata, enabled by the 3D fusion of MRI and metabolic images, revealed considerable heterogeneity in the anatomic and metabolic profiles of grafted tissue, both within and between Huntington's disease patients. Our results demonstrate the usefulness of PET measurements of brain glucose metabolism in understanding the effects of foetal grafts in patients with Huntington's disease.

[1]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[2]  I. Shoulson,et al.  Huntington disease , 1981, Neurology.

[3]  R. Hichwa,et al.  PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.

[4]  Anne-Catherine Bachoud-Lévi,et al.  Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.

[5]  R. Ridley,et al.  Functional integration of striatal allografts in a primate model of Huntington's disease , 1998, Nature Medicine.

[6]  J. Brandt,et al.  The neuropsychology of Huntington's disease , 1986, Trends in Neurosciences.

[7]  Isabelle Bloch,et al.  Fast Nonsupervised 3D Registration of PET and MR Images of the Brain , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  T. Robbins,et al.  Cognitive functions and corticostriatal circuits: insights from Huntington's disease , 1998, Trends in Cognitive Sciences.

[9]  P. Remy,et al.  Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease , 2000, Experimental Neurology.

[10]  B. Bussel,et al.  Functional anatomy of neuropsychological deficits after severe traumatic brain injury , 1999, Neurology.

[11]  K. Wictorin,et al.  Anatomy and connectivity of intrastriatal striatal transplants , 1992, Progress in Neurobiology.

[12]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—II. In vivo monitoring of gaba release in globus pallidus and substantia nigra , 1988, Neuroscience.

[13]  J C Mazziotta,et al.  Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. , 1992, Archives of neurology.

[14]  H. Herzog,et al.  Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.

[15]  Elena Cattaneo,et al.  Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.

[16]  Françoise Condé,et al.  Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease , 1998, Nature Medicine.

[17]  O. Lindvall,et al.  Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT‐HD) , 1996, Movement disorders : official journal of the Movement Disorder Society.

[18]  D. Joel,et al.  Open interconnected model of basal ganglia‐thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[19]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching , 1988, Neuroscience.

[20]  T. Deacon,et al.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway , 1988, Neuroscience.

[22]  L. Raymond,et al.  Influence of lamotrigine on progression of early Huntington disease , 1999, Neurology.

[23]  P Boesiger,et al.  Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. , 1996, Brain : a journal of neurology.

[24]  M. Peschanski,et al.  Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.

[25]  J. Mazziotta,et al.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. , 1987, The New England journal of medicine.

[26]  V. Sossi,et al.  Bilateral human fetal striatal transplantation in Huntington's disease. , 2002, Neurology.